AVNT
Avient Corporation
Basic Materials · Chemicals - Specialty
Deeply Undervalued·Quality 55·RSI 45·DCF +173%·Conviction 75
Investment Thesis — Avient Corporation
The market is deeply mispricing Avient, fixated on recent negative returns and an apparent dividend distortion (likely a data error or one-time event) that has fueled extreme short interest. This overlooks a robust forward earnings outlook, indicated by a deeply discounted forward P/E, suggesting a significant rebound in profitability is anticipated but not yet priced in.
Catalysts
- Strong Q1/Q2 2024 earnings beats, validating the forward EPS projections.
- Significant reduction in short interest as bearish bets unwind.
- Successful integration of recent acquisitions or strategic divestitures improving margin profile.
Risk Factors
- Global economic slowdown impacting demand for basic materials.
- Failure to achieve anticipated cost synergies or margin expansion.
- Persistent high raw material costs eroding profitability.
Key Debates
P/E compresses to 13.5x by H2 2024 as earnings recover
Net Margin expands to 5% by Q3 2024, doubling EPS
ROE exceeds 6% by Q4 2024 as debt is reduced